Over 100 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey at Pre-Filled Syringes America 2015 to discuss the latest achievements in the pre-filled syringe marketplace, developments in human factor studies, device development, regulations and more. Find out how to deliver your product to market with 2 days of interactive presentations, case studies, networking sessions and 2 workshops.
Benefits of attending Pre-Filled Syringes America 2015:
• Listen to keynote addresses from the leaders in human factors engineering with expert input on reaching certain patient populations, considerations and compliance in device design and how can we ensure the drug product is administered safely and effectively
• Learn about the critical issues surrounding safety assessments of pre-filled syringes from extractables and leachables to sterility and needle stick prevention requirements –NEW FOR 2015
• Enhance your understanding of labelling and pricing considerations with the competitive market for biosimilars set to storm with patent expiries due
• Assess the future of pre-filled syringes with case study led presentations addressing the challenges faced with parenteral packaging innovations and reviewing the strategies needed to overcome the hurdles with importance insights into autoinjectors and pens
• Address the use of lyophilisation in pre-filled syringes, is this the future vision?
Expert Speaker Panel 2015 includes:
• William Beierschmitt, Associate Research Fellow, Pfizer, Inc.
• Edmond Israelski, Program Manager, Abbott Laboratories
• Natalia Mazaeva, Usability Leader, Sanofi-Aventis
• Dena Flamm, Product Manager, Bosch Packaging Technology
• Ben Bartfeld, Human Factors and Industrial Design Consultant, Otsuka Pharmaceuticals
• Saikrishna Garrepalli, Procurement Management Representative, Beroe Inc
• Stephen Barat, Senior Director, Toxicology and Operations, Forest Laboratories
• Kiran Singh, Associate Director, Sandoz Pharmaceuticals
• Pei-Yang Phillip Hsu, Chief Executive Officer, SaferMed Technologies
• Ravi S. Harapanhalli, Vice President and Former FDA Senior Executive, Parexel International
• Michel Mikhail, Former Chief Regulatory Officer, Executive VP, Global regulatory - Governmental Relations, Fresenius Kabi NV/SA
• Shun Ogawa, Research Manager, Mitsubishi Gas Chemical Company Inc.
• Royce Brockett, Senior Product Manager, West Pharmaceutical Services, Inc.
• Scott Brown, Device Development Lead, Merck & Co Inc
• Li-Chun Tsou, Global Device Technical Director, AstraZeneca
• Mark Tsai, Principal Engineer, Drug Delivery, Johnson And Johnson
• Aarti Gidh, Principal Scientist, GlaxoSmithKline
• Chanderkanth Gautham, Senior Research Analyst, Beroe Inc
Plus, two interactive half-day post conference workshops:
(Wednesday, 29th April 2015, Renaissance Woodbridge Hotel, Iselin, New Jersey, USA)
1) Advanced delivery systems to enable personalised medicines
Hosted by: Ravi S. Harapanhalli, Vice President, and Mr. Sall, Principal Consultant, ParExel
2) Will Drug Delivery in Coming Days be an Integral Part of DDM?- Diagnose, Deliver and Monitor
Hosted by: Chanderkanth Gautham, Domain Lead of Medical Device Team, and Saikrishna Garrepalli, Procurement Management Representative, Beroe Inc.
Event BrochureVenue:
To Be AnnouncedOrganiser Contact Details:
Julia RotarT:
+44 (0) 20 7827 6088jrotar@smi-online.co.uk
